Response Variability to Psychotropic DrugsW. Janke |
From inside the book
Results 1-3 of 9
Page 251
... iproniazid group show that patients who have pretreatment paranoid symptoms may show less remissive change in depression than people who are free of such symptoms . In the iproniazid group the patients who had suicidal tendencies showed ...
... iproniazid group show that patients who have pretreatment paranoid symptoms may show less remissive change in depression than people who are free of such symptoms . In the iproniazid group the patients who had suicidal tendencies showed ...
Page 253
... iproniazid group , it is apparent that the paranoid patients lost less anxiety than the nonparanoid patients . In ... iproniazid ) versus no treatment ( i.e. placebo ) as forming a dichotomized variable in a composite sample which com ...
... iproniazid group , it is apparent that the paranoid patients lost less anxiety than the nonparanoid patients . In ... iproniazid ) versus no treatment ( i.e. placebo ) as forming a dichotomized variable in a composite sample which com ...
Page 254
... iproniazid or placebo . Whether a patient receives iproniazid is not the only factor in symptomatic remission , and it may not be the most important . It may be noted in this composite sample , however , that diminution of depressive ...
... iproniazid or placebo . Whether a patient receives iproniazid is not the only factor in symptomatic remission , and it may not be the most important . It may be noted in this composite sample , however , that diminution of depressive ...
Contents
Drug Response Variability Overview of Contributing Factors | 31 |
Somatic factors as predictors of psychotropic drug response | 67 |
Genetic and early environmental factors in response variability | 97 |
Copyright | |
9 other sections not shown
Other editions - View all
Common terms and phrases
activity administration adrenergic drugs alcohol amitriptyline analysis antidepressant anxiety arousal behavioral biochemical blood levels changes chlordiazepoxide chlorpromazine Claridge Clin clinical concentration correlation Debus depressant drugs depressed patients diazepam DiMascio dose drug effects drug metabolism drug postulate drug response variability drug tolerance emotional responses environmental and situational enzyme evidence experiment experimental extraverts females genetic factors H. J. Eysenck hexobarbitone imipramine increase individual differences influence interaction introverts investigated iproniazid Janke kinetic Lienert lofepramine male measures ment meprobamate neurotic neuroticism nicotine nortriptyline orciprenaline performance personality traits pharmacokinetic Pharmacol pharmacological physiological placebo plasma levels prediction predictors pretreatment Psychiatry psychoactive drugs Psychol psychological psychopharmacology psychotropic drugs questionnaire reactions relationship reported response variability sample sedation threshold significant situational conditions smoking behaviour somatic specific stimulant studies subjects scoring symptoms Table theory therapeutic tion tranquilizers treatment variability to psychotropic variance Wesnes Wittenborn